Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Research and development	$ 2,270	$ 2,253
General and administrative	1,820	2,152
Total operating expenses	4,090	4,405
Operating loss	(4,090)	(4,405)
(Loss) gain on debt extinguishment, net	(22)	14,520
Change in fair value of common stock warrant liability	134	0
Interest income	7	30
Interest expense	(20)	(13)
Other (expense) income, net	(54)	201
Total other income, net	45	14,738
(Loss) income before income taxes	(4,045)	10,333
Income tax expense	0	(114)
Net (loss) income	(4,045)	10,219
Dividends on Series C preferred stock	(998)	0
Net (loss) income attributable to common stockholders	$ (5,043)	$ 10,219
Net (loss) income per share attributable to common stockholders
Basic and diluted (in dollars per share)	$ (4.63)	$ 1,099.37
Weighted average number of common shares outstanding
Basic and diluted (in shares)	1,088,564	9,295